Effect of Calycosin on Human Breast Cancer Cell Line MCF-7 in Vitro

KUANG Wen-juan,LIU Li-tao,TAN Xian-shu,DUAN Ying,ZHOU Li-ming
DOI: https://doi.org/10.3781/j.issn.1000-7431.2011.09.003
2011-01-01
Tumori
Abstract:Objective: To investigate the effect of calycosin on estrogen receptor-positive human breast cancer MCF-7 cells in vitro , and to elucidate the posssible mechanism. Methods: Human breast cancer MCF-7 cells were treated with different concentrations of calycosin. The untreated group and 17-estradiol (E2) -positive group were used as the controls. Then cell proliferation was detected by MTT assay, the apoptosis rate was examined by flow cytometry, and the mRNA and protein levels of Bcl-2 and Bax were determined by reverse transcription-polymerase chain reaction (RT-PCR) and immunocytochemistry, respectively. Results: Calycosin at the low concentrations of 2, 4 and 8 μmol/L stimulated the proliferation of MCF-7 cells compared with solvent control, whereas calycosin at the concentrations of 16 and 32 μmol/L inhibited cell proliferation in a dose-dependent manner. Calycosin at the low concentrations of 2, 4 and 8 μmol/L decreased the percentage of early apoptosis in MCF-7 cells (P <0.05), down-regulated mRNA and protein levels of Bax and up-regulated those of Bcl-2 (P <0.05). Conclusion: Calycosin at low concentrations can promote the proliferation of MCF-7 cells and inhibit the apoptosis, which may be due to its estrogenic action. DOI: 10.3781/j.issn.1000-7431.2011.09.003
What problem does this paper attempt to address?